Literature DB >> 24860779

Elastosis perforans serpiginosa.

Ludimila Noleto de Rezende1, Mónica Gauto Nuñez1, Thaís Genn Clavery1, Eneida Genn Constancio2, Mayra Carrijo Rochael3, Gabriela Juncá T Pires2, Omar Lupi4.   

Abstract

Entities:  

Year:  2014        PMID: 24860779      PMCID: PMC4030372          DOI: 10.4103/2229-5178.131156

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
A 22-year-old male patient, African descent, in august 2011, complained of “dots in his arms,” for one year duration, associated with slight pruritus. The patient had obesity level II and high blood pressure, on regular hydrochlorothiazide and losartan. On clinical examination, erythematous papules with central crusts, coalescing to form serpiginous lesions were seen over arms, [Figures 1 and 2]. It was suggestive of elastosis perforans serpiginosa (EPS) and a biopsy was carried out in the right arm lesions.
Figure 1

Erythematous papules with central crusts, coalescing to form serpiginous lesions over right arm

Figure 2

Close up view of the right arm

Erythematous papules with central crusts, coalescing to form serpiginous lesions over right arm Close up view of the right arm Histopathological examination of the material, subjected to special Weigert staining, showed fragmented elastic fibers in the base of the perforation, with less intense staining of epidermal depression [Figures 3 and 4]. Therefore, the diagnosis was confirmed.
Figure 3

fragmented elastic fibers in the base of the perforation

Figure 4

less intense staining of epidermal depression

fragmented elastic fibers in the base of the perforation less intense staining of epidermal depression EPS is a rare skin condition included among the primary perforating dermatoses of dermal origin characterized by the transepidermal extrusion of elastic fibers. The etiopathogenesis may be considered idiopathic or associated with Down's syndrome, hereditary diseases of the connective tissue, and the use of D-penicillamine.[1] EPS should be suspected in a patient presenting with keratotic papules, asymptomatic or pruriginous plaques grouped in an arciform or serpiginous pattern. The diagnosis is confirmed by histopathology (gold standard). Clinically, the differential diagnoses are granuloma annulare, tinea corporis, annular sarcoidosis, cutaneous calcinosis, and porokeratosis of Mibelli. The treatment options explored in published articles were cryotherapy, topical tretinoin, 0.1% tazarotene gel, oral isotretinoin, imiquimod, carbon dioxide laser (CO2 laser) and pulsed dye laser, all these results with some constant, varying greatly between authors.[234] In this case, patient was given the option of treatment with CO2 laser and cryotherapy. The patient opted for cryotherapy and after the first session, the lesions showed partial improvement, with mild hypochromia in some larger lesions.
  4 in total

1.  Treatment of elastosis perforans serpiginosa with the flashlamp pulsed dye laser.

Authors:  A J Kaufman
Journal:  Dermatol Surg       Date:  2000-11       Impact factor: 3.398

2.  Elastosis perforans serpiginosa: treatment with liquid nitrogen.

Authors:  E J Tuyp; W A McLeod
Journal:  Int J Dermatol       Date:  1990-11       Impact factor: 2.736

Review 3.  D-penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature.

Authors:  Laura Atzori; Anna Luisa Pinna; Monica Pau; Nicola Aste
Journal:  Dermatol Online J       Date:  2011-04-15

4.  Penicillamine-induced elastosis perforans serpiginosa treated successfully with isotretinoin.

Authors:  R C Ratnavel; P G Norris
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

  4 in total
  2 in total

1.  Elastosis perforans serpiginosa: a review of the literature and our own experience.

Authors:  Adriana Polańska; Monika Bowszyc-Dmochowska; Ryszard W Żaba; Zygmunt Adamski; Adam Reich; Aleksandra Dańczak-Pazdrowska
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

2.  Acquired reactive perforating collagenosis: A report of a typical case.

Authors:  Chengwen Fei; Yao Wang; Yu Gong; Hui Xu; Qian Yu; Yuling Shi
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.